Drug General Information
Drug ID
D0N7JZ
Former ID
DIB012408
Drug Name
SAND-26
Synonyms
Begedina; CD26-targeting antibody (autoimmunity), ADIENNE
Drug Type
Antibody
Indication Autoimmune diabetes [ICD10:E08-E13] Phase 3 [525143], [543248]
Company
ADIENNE Pharma & Biotech
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info [551687]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 525143ClinicalTrials.gov (NCT02411084) Study of BEGEDINA vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD. U.S. National Institutes of Health.
Ref 543248(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8691).
Ref 551687Clinical pipeline report, company report or official report of Siesonline.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.